Celcuity Inc.

NasdaqCM:CELC Stok Raporu

Piyasa değeri: US$568.8m

Celcuity Yönetim

Yönetim kriter kontrolleri 4/4

Celcuity CEO'su Brian Sullivan, Jan2012 tarihinde atandı, in görev süresi 12.83 yıldır. in toplam yıllık tazminatı $ 1.74M olup, şirket hissesi ve opsiyonları dahil olmak üzere 12.1% maaş ve 87.9% ikramiyelerden oluşmaktadır. şirketin hisselerinin 8.15% ine doğrudan sahiptir ve bu hisseler $ 46.34M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 9.3 yıldır.

Anahtar bilgiler

Brian Sullivan

İcra Kurulu Başkanı

US$1.7m

Toplam tazminat

CEO maaş yüzdesi12.1%
CEO görev süresi12.8yrs
CEO sahipliği8.1%
Yönetim ortalama görev süresi3.8yrs
Yönetim Kurulu ortalama görev süresi9.3yrs

Son yönetim güncellemeleri

Recent updates

Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Aug 31
Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Celcuity: Flying A Phase 3 Trial Right Under Your Nose

Jul 05

Does Celcuity (NASDAQ:CELC) Have A Healthy Balance Sheet?

May 08
Does Celcuity (NASDAQ:CELC) Have A Healthy Balance Sheet?

Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Jul 04
Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Is Celcuity (NASDAQ:CELC) A Risky Investment?

Sep 13
Is Celcuity (NASDAQ:CELC) A Risky Investment?

Celcuity rises after hours on FDA Breakthrough Therapy nod for its breast cancer treatment

Jul 18

Is Celcuity (NASDAQ:CELC) A Risky Investment?

Jan 27
Is Celcuity (NASDAQ:CELC) A Risky Investment?

Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?

Sep 21
Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?

Celcuity: Nipping The Oncogenic Bud

Jul 08

What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition

Mar 14
What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition

We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely

Jan 20
We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely

Celcuity inks clinical trial pact with Massachusetts General Hospital and Puma Technologies

Dec 23

Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?

Nov 29
Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?

Celcuity EPS beats by $0.03

Nov 09

CEO Tazminat Analizi

Brian Sullivan'un ücretlendirmesi Celcuity'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$83m

Mar 31 2024n/an/a

-US$73m

Dec 31 2023US$2mUS$210k

-US$64m

Sep 30 2023n/an/a

-US$57m

Jun 30 2023n/an/a

-US$49m

Mar 31 2023n/an/a

-US$45m

Dec 31 2022US$2mUS$106k

-US$41m

Sep 30 2022n/an/a

-US$36m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$35m

Dec 31 2021US$1mUS$260k

-US$30m

Sep 30 2021n/an/a

-US$25m

Jun 30 2021n/an/a

-US$22m

Mar 31 2021n/an/a

-US$10m

Dec 31 2020US$469kUS$250k

-US$9m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$8m

Dec 31 2019US$992kUS$250k

-US$7m

Sep 30 2019n/an/a

-US$7m

Jun 30 2019n/an/a

-US$7m

Mar 31 2019n/an/a

-US$7m

Dec 31 2018US$564kUS$250k

-US$7m

Sep 30 2018n/an/a

-US$7m

Jun 30 2018n/an/a

-US$7m

Mar 31 2018n/an/a

-US$7m

Dec 31 2017US$490kUS$232k

-US$6m

Tazminat ve Piyasa: Brian 'ın toplam tazminatı ($USD 1.74M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 2.40M ).

Tazminat ve Kazançlar: Brian 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Brian Sullivan (62 yo)

12.8yrs

Görev süresi

US$1,738,115

Tazminat

Mr. Brian F. Sullivan is the Co-Founder of Celcuity Inc. and has been its Chairman and Chief Executive Officer since 2012 and served as its Chief Financial Officer. Mr. Sullivan Co-founded Entegris, Inc. i...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Brian Sullivan
Co-Founder12.8yrsUS$1.74m8.15%
$ 46.3m
Lance Laing
Co-Founder12.8yrsUS$1.48m3.38%
$ 19.2m
Vicky Hahne
Chief Financial Officer7.3yrsUS$898.74k0.050%
$ 285.0k
Brent Eilefson
General Counselless than a yearVeri yokVeri yok
John MacDonald
Senior Vice President of R&D3.8yrsVeri yokVeri yok
Sheri Smith
Acting Head of Clinical Operations3.8yrsVeri yokVeri yok
Igor Gorbatchevsky
Chief Medical Officer2.7yrsVeri yokVeri yok
Eldon Mayer
Chief Commercial Officerless than a yearVeri yokVeri yok
Charlotte Moser
Senior Vice President of Clinical Developmentless than a yearVeri yokVeri yok

3.8yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim: CELC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Brian Sullivan
Co-Founder12.8yrsUS$1.74m8.15%
$ 46.3m
Lance Laing
Co-Founder12.8yrsUS$1.48m3.38%
$ 19.2m
Richard Nigon
Independent Director7.8yrsUS$87.50k0.27%
$ 1.6m
David Dalvey
Independent Director10.8yrsUS$87.50k0.025%
$ 143.2k
Leo Furcht
Independent Director5.5yrsUS$87.50k0.028%
$ 161.3k
Ronald McGlennen
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Edward Greeno
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Sara A. Hurvitz
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Carol Lange
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Benita Katzenellenbogen
Member of Scientific Advisory Boardno dataVeri yokVeri yok
John Katzenellengogen
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Mothaffar Rimawi
Member of Scientific Advisory Board5.8yrsVeri yokVeri yok

9.3yrs

Ortalama Görev Süresi

66yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CELC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.3 yıldır).